Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15
Trulieve Cannabis Corp TRLV
$8.65
▲ +0.93%
(+$0.08)
📅 Earnings This Week
Open
$8.44
Prev Close
$8.57
Day Range
$8.20 – $8.68
52W Range
$7.82 – $12.30
Market Cap
$1.66B
Beta
1.06
EPS (TTM)
$-0.42
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2018-09-25 |
| Shares Out. | 192,310,000 |
| Website | trulieve.com/ ↗ |
| Phone | 18502988866 |
| Employees | 5,000 |
About Trulieve Cannabis Corp
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
Trulieve Cannabis Corp is a publicly traded company under the ticker symbol TRLV on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
12 analysts (2026-07-01)